论文部分内容阅读
目的评价临床路径应用于前列腺电切术患者的费用-效益。方法 2009-05-2010-05因良性前列腺增生症行前列腺电切术的患者165例,随机分为临床路径治疗模式组(路径组)和常规治疗模式组(常规组)。路径组治疗过程严格按照路径表格,实施标准化的治疗。常规组采用常规治疗模式。以其平均住院日、住院费用等作为评价指标,进行对比分析。结果路径组和常规组在平均住院日、住院费用等方面差异有统计学意义(P<0.01),路径组费用-效益比值较小。结论临床路径应用于前列腺电切术患者,可明显缩短平均住院时间,降低治疗费用,有良好的费用-效益比。
Objective To evaluate the cost-effectiveness of clinical pathology in patients undergoing prostatectomy. Methods A total of 165 patients with benign prostatic hyperplasia (BPH) undergoing prostatectomy were randomly divided into treatment group (path group) and conventional treatment group (conventional group). Path group treatment in strict accordance with the path of the table, the implementation of standardized treatment. The conventional group used conventional treatment mode. With its average length of stay, hospitalization costs as the evaluation index, a comparative analysis. Results There were significant differences in average length of hospitalization and hospitalization between the pathological group and the conventional group (P <0.01), and the cost-benefit ratio of the path group was smaller. Conclusion The clinical pathway applied to patients with prostatectomy can significantly reduce the average length of stay, reduce the cost of treatment, there is a good cost-benefit ratio.